Recorded fact · drug.label_indication
drug.label_indication for secukinumab|psoriasis
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 8ce680ba resolves to.
The record
| Fact id | 8ce680bacb9efc648e5ba460 |
|---|---|
| Entity | drug: secukinumab|psoriasis |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260825 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
moderate to severe plaque psoriasis (PsO) in adults and pediatric patients 6 years and older who are candidates for systemic therapy or phototherapy.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 4302ae0234ca646890f3a177ecf899ddc920267eebf6aa79cf59d8cd3e6ce29d.
The value
{
"ingredient": "SECUKINUMAB",
"conditionId": "psoriasis",
"conditionName": "Psoriasis",
"matchedAlias": "psoriasis",
"context": "indication",
"brand": "COSENTYX",
"identifiedVia": "product_elements",
"extractor": 5,
"labelSetId": "77c4b13e-7df3-42d4-81db-3d0cddb7f67a",
"labelEffectiveTime": "20260825",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: c91f226b9b2e10bbe43bfb7756a89a2fdd45f6d564086726c611bc0f30a5b219.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.